Recent Insider Transactions - Monopar Therapeutics (NASDAQ: MNPR)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ MNPR Monopar Therapeutics

Radhakrishnan Karthik / officer: Chief Financial Officer

10/28/2024

Buy

$16.25

1,550

$25K

1,550

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

09/30/2024

Sell

$6.74

1,918

$13K

56,162

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

09/30/2024

Sell

$6.74

535

$4K

39,869